The CDC formally recommends several new serologic assay testing methods recently cleared by the FDA. The Lyme disease serologic assays, which utilize a sensitive enzyme immunoassay (EIA) for detecting pathogens, were cleared by the FDA on July 29th, 2019 and have since been determined to be acceptable alternatives for the serologic diagnosis of Lyme disease […]
Govt. Departments & Agencies
The Government Department & Agencies section on the submenu includes federal government departments such as Health & Human Services (HHS), Department of Defense (DoD), and Department of Education (USDE). Often agencies under these departments adopt policies that affect Lyme & TBD, such as those from the CDC and NIH, both agencies are under HHS. The HHS Tick-Borne Disease Working group can be found under HHS. Military can be found under DoD. From time to time, the LDA will post articles in these sections that pertain to Lyme disease/TBD that might be of interest or importance to the public, including policies and rule making being considered or adopted.
Candy Brassard, Senior Biologist, U.S. Environmental Protection Agency Office of Pesticide Programs; C. Ben Beard, PhD, Director, Bacterial Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control & Prevention at a Meeting at EPA on Lyme in Virginia in 2006.
As part of the Pentagon’s second annual “Bug Week,” an event organized to raise awareness of insects and the diseases they carry, the Defense Department announced its plans to develop a new and improved product that will eventually replace permethrin, the repellent and insecticide currently used to soak most military combat uniforms to protect against […]
The Department of Health and Human Services (HHS) gave notice that the Tick-Borne Disease Working Group (TBDWG) will hold a public meeting via webcast on September 12, 2019, from 8:30 a.m. to 5 p.m. ET (times are tentative and subject to change). At the upcoming meeting, the TBDWG will receive updates from eight subcommittees that […]
TO: Lyme Disease Advocates & Patients FROM: Lyme Disease Association, Inc. Pat Smith, President, 8-15-19 RE: Urgent & Immediate Help Needed to Investigate Information Which Could Lead to Helping to Solve Tick-Borne Diseases Problem ISSUE: The debate over the prevalence of Lyme disease and whether it exists in a chronic form has raged for decades. […]
The federal Tick-Borne Disease Working Group (TBDWG) held their ninth meeting in D.C. on June 4, 2019 with a focus on developing the next report to be drafted for the HHS Secretary and Congress. The report will include an update on federal tick-borne disease activities and research findings. Read Meeting Summary and Written Public Comments […]
The Lyme Disease Association announces that the Food and Drug Administration (FDA) yesterday cleared for marketing four previously cleared tests for the diagnosis of Lyme disease. Called the modified two-tier, enzyme immune assay, (EIA), the new tests are able to be run at the same time or sequentially. The current two-tier testing has an EIA […]
Congressman Christopher Smith (R-NJ-04) has been pushing for funding and recognition of Lyme and tick-borne diseases over the past 27 years. On July 9, 2019, Mr. Smith testified before the Committee on Rules and introduced two amendments relating to Lyme and tick-borne diseases to the Defense Authorization Bill (National Defense Appropriations Act). ONE PASSED RULES […]
Patricia V. Smith, has been appointed as one of the public members of the new panel for Health and Human Services Tick-Borne Disease Working Group (TBDWG). Pat is in her 22 year as President of the all-volunteer run national non-profit Lyme Disease Association (LDA) and has been a leading voice and advocate for patients for […]
Lorraine Johnson, JD, MBA, Chief Executive Officer of LymeDisease.org delves into the importance of meaningful patient representation on the Federal HHS Tick-Borne Disease Working Group (TBDWG) in her latest blog. This is especially important as we await the announcement of panelists to the new TBDWG charged with the next report to Congress due in 2020. […]
Since 2016, the Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease Research Program (TBDRP) has received a $5 million Congressional appropriation each year to allocate to awardees focused on Lyme disease research or research on other tick-borne disease (TBDs). Awards address at least one of four TBDRP focus areas which include diagnosis, treatment, prevention, and […]